DR JANSSEN CHRISTOPHE
ActiveFrom the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
DR JANSSEN CHRISTOPHE has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €74,836. Equity has been shrinking by about 7.7% per year since 2019. Its solvency ranks better than 10% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 09-08-2018 Normal situation
- Activity
- Specialist medical practice NACE 86220and 1 other
- Establishment unit
- 2.278.312.145 7090 Braine-le-Comte, since 09-08-2018
- Financial year end
- 30 June
- Peppol
- Reachable since 15-03-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €182,156
- ▲ 20.7%
- Turnover
- ≈ €340,000
- estimated
- Profit
- €74,836
- ▲ 7.6%
- Equity
- €18,600
- ▼ 78.9%
- Total assets
- €368,084
- ▲ 34.0%
Score breakdownraises riskEquity €18,600 (5.1% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.90, cash €296,591Size: total assets €368,084Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 10% of them on solvency, 20% on liquidity, 13% on profitability and 7% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 5 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Equity fell in 2025from €88,122 to €18,600 ▼ 78.9% View
- Caution: Lower solvency than 89% of companies in human healthsector median 63.0% · 20,678 companies 5.1% View
- Positive: 7 profitable years in a rowprofit 2025: €74,836 7 years View
- Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
Comparable companies
These companies have the same main activity as DR JANSSEN CHRISTOPHE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €352,000 and €399,000, founded between 2018 and 2019.
| Company | Total assets | Gross margin |
|---|---|---|
| DR JANSSEN CHRISTOPHE Braine-le-Comte | €368,084 | €182,156 |
| Dr ABSIL Bruno Grez-Doiceau | €384,378 | €184,478 |
| Dr. C. Kesteloot Grimbergen | €364,478 | €179,596 |
| Dokter Singh skb psychiatrie Rotselaar | €352,470 | €173,698 |
| Dr. Lore Leempoels Leuven | €356,512 | €170,794 |
| Dr. Vandenberghe Johan Menen | €362,342 | €188,412 |
| DR. VOLCKAERT KARLIEN, FYSISCHE GENEESKUNDE Dilbeek | €399,456 | €170,202 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 16-01-2026
- Annual accounts 2024filed on 27-01-2025
- Annual accounts 2023filed on 24-01-2024
- Annual accounts 2022filed on 26-01-2023
Acts in the Belgian Official Gazette
- Purpose · Amendment of the articles · Legal-form change · Resignations & appointmentsact of 22-07-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about DR JANSSEN CHRISTOPHE
- What is the company number of DR JANSSEN CHRISTOPHE?
- The company number of DR JANSSEN CHRISTOPHE is 0700.780.854. The VAT number is the same number with BE in front: BE 0700.780.854.
- Where is DR JANSSEN CHRISTOPHE based?
- The registered office is at Chemin de Feluy 89, 7090 Braine-le-Comte.Company details
- What does DR JANSSEN CHRISTOPHE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR JANSSEN CHRISTOPHE?
- The legal form of DR JANSSEN CHRISTOPHE is Private limited company (BV).
- When was DR JANSSEN CHRISTOPHE founded?
- DR JANSSEN CHRISTOPHE was founded on 09-08-2018.
- Is DR JANSSEN CHRISTOPHE still active?
- Yes, DR JANSSEN CHRISTOPHE is an active enterprise in the KBO register.
- What is the turnover of DR JANSSEN CHRISTOPHE?
- The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €182,156 and 43 comparable companies (NACE 86220). It probably lies between €290,000 and €450,000.Financials
- Is DR JANSSEN CHRISTOPHE profitable?
- In financial year 2025, DR JANSSEN CHRISTOPHE made a profit of €74,836.
- Where can I find the annual accounts of DR JANSSEN CHRISTOPHE?
- DR JANSSEN CHRISTOPHE filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of DR JANSSEN CHRISTOPHE due?
- DR JANSSEN CHRISTOPHE must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.